Back to Treatments

Treatment

Bevacizumab (added to chemotherapy)

1
Conditions
2
Trials
25K
Participants
35%
Average Safety

Condition Evidence

Colon and rectum cancer

2 trials · 25K participants

75% effectiveness · 35% safety
Bevacizumab (added to chemotherapy) | DFDA